sanofi.comSanofi: global healthcare and pharmaceutical company

Our Company Our Company Our Strategy Governance Governance Board of Directors Executive Committee Specialist Committees Social Impact Social Impact Access to Healthcare Innovation for Vulnerable Communities Environmental Sustainability and Resilience Diversity, Equity, and Inclusion In and Beyond the Workplace Code of Conduct and Responsible Business Our Legacy Our Science Our Science Our Pipeline R&D Focus Areas R&D Focus Areas Immunology R&D Neurology R&D Oncology R&D Rare Blood Disorders R&D Rare Diseases R&D Vaccines R&D Artificial Intelligence in R&D Technology Platforms Clinical Trials & Results Clinical Trials & Results Find a Clinical Trial Clinical Study Results Investigator Sponsored Studies Diversity in Clinical Trials Scientific Collaboration Scientific Collaboration Scientific Collaboration in North America Scientific Collaboration in Europe Scientific Collaboration in China Digital Your Health Your Health Vaccines Vaccines Pertussis Respiratory Syncytial Virus Production Why vaccines matter Influenza Meningococcal Meningitis Medicines Medicines Immunology Neurology Oncology Rare Blood Disorders Rare Diseases Cardiovascular Diseases Diabetes Consumer Healthcare Consumer Healthcare Sustainability at Sanofi Consumer Healthcare Allergy Cough, Cold & Flu Digestive Wellness Pain Care Physical & Mental Wellness Patient Support Healthcare Professionals Support Healthcare Professionals Support Managed Access Programs (MAPs) Pre-Registration Import Licenses Post Trial Access (PTA) Partnering Partnering Partnering Focus Areas Partnering Focus Areas China Digital General Medicines Immunology Neuroscience Oncology Out-Licensing Rare Disease Technology Platforms Vaccines Meet the Partnering Team Contact Business Development Team Media Media Media Contacts Magazine Sanofi Today Press Releases Investors Investors News Financial Results and Investor Events Financial Results and Investor Events Results Presentations Conferences Individual Investors Environment, Social, Governance Environment, Social, Governance Our Double Materiality Assessment Our Latest ESG news ESG quarterly update Shares and ADRs Shares and ADRs Sanofi stock chart Dividend ADRs Shareholding structure Vara consensus Shares & voting rights Share repurchases Bonds Financial Reports and Publications Financial Reports and Publications Financial Reports and Regulated Information Shareholder publications Financial Reporting Center and Key Data Contacts Careers Careers All Well Global Terms and Conditions Paris 2024 Paris 2024 Meet Team Sanofi Follow the Paris 2024 Olympic and Paralympic Torches Relays Global Stefanie Kutschmann, Good Manufacturing Practice Officer, Frankfurt, Germany Stefanie Kutschmann, Good Manufacturing Practice Officer, Frankfurt, Germany First quarter 2024 results First quarter 2024 results were reviewed by management during a conference call with the financial community on April 25th. The presentation was followed by a Q&A session. Discover more Our Latest News Read our latest articles Social Impact May 13, 2024 Raise Your Voice: Our Annual DE&I Report Read the article Our Science April 29, 2024 All in on AI, Environmentally Responsible Read the article Our Science April 22, 2024 Sanofi at VivaTech Read the article United by Purpose Each of us plays a unique role in bringing our purpose to life. Sanofi X Paris 2024 We’re proud to be premium partner of Paris 2024. Science and sport aren’t that different. Just like athletes do, we overcome setbacks to keep moving forward, not just for ourselves, but for our patients, colleagues, families and friends. Read more about the partnershipWho We Are We are an innovative global healthcare company. Read more Our Science We turn the impossible into possible. Read more Your Health We chase the miracles of science to improve people’s lives. Read more Our Commitment We have reimagined a bold sustainable approach. Read more Our Pipeline 5 Therapeutic areas 77 Compounds in clinical development 28 Clinical trials in phase 3 Explore our pipeline Explore Career Opportunities You’ll be surprised what you can achieve at Sanofi. Discover your future here. Access Career Portal Our Latest Press Releases May 13, 2024 Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty Read the Press Release May 10, 2024 Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines Read the Press Release May 2, 2024 Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizations Read the Press Release April 30, 2024 Press Release: Annual General Meeting of April 30, 2024 Read the Press Release See all press releases Follow usContact Legal notice Privacy & data protection Cookies Policy Sanofi Today Our publications Sitemap Directory Accessibility: partial compliance Code of Conduct © Sanofi 2004-2024 - All rights...